Twist Bioscience (TWST) Assets (2018 - 2026)

Twist Bioscience (TWST) has 9 years of Assets data on file, last reported at $676.2 million in Q1 2026.

• Assets for Q1 2026 came in at $676.2 million, up 13.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $676.2 million (up 13.53% YoY), and the FY2025 annual result was $641.9 million, up 4.48% from the prior year.
• Assets climbed to $676.2 million in Q1 2026 per TWST's latest filing, from $638.1 million in the prior quarter.
• Over five years, Assets peaked at $1.0 billion in Q1 2022 and troughed at $595.6 million in Q1 2025.
• A 5-year average of $753.3 million and a median of $702.8 million in 2024 frame the typical range for Assets.
• The sharpest annual moves came in 2022 and 2024: Assets surged 50.84% in 2022, then retreated 21.25% in 2024.
• A 5-year view of Assets shows it stood at $910.0 million in 2022, then slipped by 19.47% to $732.8 million in 2023, then fell by 16.95% to $608.6 million in 2024, then climbed by 4.85% to $638.1 million in 2025, then gained by 5.98% to $676.2 million in 2026.
• Business Quant data shows TWST's Assets at $676.2 million in Q1 2026, $638.1 million in Q4 2025, and $641.9 million in Q3 2025.